To address the role of AGER in caspase-11 inflammasome activation, we first used FPS-ZM1, a high-affinity AGER-specific inhibitor identified from high-throughput screenings in an experimental model of Alzheimer's disease (24). Here, AGER is linked to early-onset autosomal dominant Alzheimer disease.